GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Veeva Systems VEEV · USD

Health Care · US listing · 🇺🇸 United States

S&P 500

Compare

306.40

+0.88%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$3.20bn

FY2017FY2026

Net income

$908.9m

FY2017FY2026

Free cash flow

$1.39bn

FY2017FY2026

Shareholders' equity

$7.21bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$3.20bn$2.75bn$2.36bn$2.16bn$1.85bn$1.47bn$1.10bn$862.2m$690.6m$544.0m
Gross profit$2.41bn$2.05bn$1.69bn$1.55bn$1.35bn$1.06bn$800.7m$616.9m$479.1m$370.4m
Research and development$767.4m$693.1m$629.0m$520.3m$382.0m$294.2m$209.9m$158.8m$132.1m$96.8m
Operating income$916.4m$691.4m$429.3m$459.1m$505.5m$377.8m$286.2m$222.9m$157.9m$120.7m
Net income$908.9m$714.1m$525.7m$487.7m$427.4m$380.0m$301.1m$229.8m$151.2m$77.6m
Diluted earnings per share5.514.253.192.982.632.331.861.450.970.50

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$8.98bn$7.34bn$5.91bn$4.80bn$3.82bn$3.05bn$2.27bn$1.65bn$1.23bn$917.7m
Cash and short-term investments$6.56bn$5.15bn$4.03bn$3.10bn$2.38bn$1.66bn$1.09bn$1.09bn$762.0m$518.9m
Total liabilities$1.76bn$1.51bn$1.27bn$1.09bn$904.8m$779.7m$606.2m$416.0m$324.1m$264.7m
Debt$12.2m————$400,000$1.4m———
Shareholders' equity$7.21bn$5.83bn$4.64bn$3.72bn$2.91bn$2.27bn$1.67bn$1.24bn$906.2m$653.0m
Shares outstanding165m168m165m164m162m163m162m159m156m154m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations$1.42bn$1.09bn$911.3m$780.5m$764.5m$551.2m$437.4m$310.8m$233.4m$144.0m
Capital spending−$29.1m−$20.5m−$26.2m−$13.5m−$14.2m−$8.7m−$3.1m−$8.4m−$9.6m−$6.9m
Free cash flow$1.39bn$1.07bn$885.1m$767.0m$750.2m$542.6m$434.3m$302.4m$223.8m$137.1m
Dividends paid————−$3.8m—————

Latest quarters

By quarter end

Jul 2026Apr 2026Jan 2026Oct 2025Jul 2025Apr 2025Jan 2025Oct 2024
Revenue$928.0m$882.9m$836.0m$811.2m$789.1m$759.0m$720.9m$699.2m
Gross profit$696.0m$659.7m$622.5m$611.8m$593.8m$585.2m$539.9m$524.8m
Operating income$275.0m$273.1m$245.9m$240.9m$195.9m$233.7m$188.4m$181.4m
Net income$273.4m$260.9m$244.2m$236.2m$200.3m$228.2m$195.6m$185.8m
Diluted earnings per share1.661.581.481.411.191.361.161.13
Cash from operations$238.0m$1.13bn$106.0m$192.0m$238.0m$877.0m$69.0m$164.0m
Capital spending−$8.0m−$1.0m−$7.0m−$6.0m−$6.0m−$5.0m−$4.0m−$4.0m
Free cash flow$230.0m$1.13bn$99.0m$186.0m$232.0m$872.0m$65.0m$160.0m
Total assets$9.06bn$9.13bn$8.98bn$8.10bn$8.00bn$7.77bn$7.34bn$6.45bn
Cash and short-term investments$7.24bn$7.31bn$6.56bn$6.64bn$6.40bn$6.07bn$5.15bn$5.06bn
Debt$14.6m$13.1m$12.2m$10.5m$10.7m$10.7m$10.0m$9.2m
Shareholders' equity$7.43bn$7.30bn$7.21bn$7.04bn$6.64bn$6.21bn$5.83bn$5.50bn

Financial ratios

Data as of 22 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin75.5%74.5%71.3%71.7%72.8%72.1%—
Operating margin28.7%25.2%18.2%21.3%27.3%25.8%—
Net margin28.4%26.0%22.2%22.6%23.1%25.9%—
Return on equity12.6%12.2%11.3%13.1%14.7%16.8%—
Return on assets10.1%9.7%8.9%10.2%11.2%12.5%—
Free cash flow yield3.3%2.5%2.2%1.9%1.8%1.3%—
Revenue growth16.3%16.2%9.7%16.4%26.3%32.7%—
Earnings growth27.3%35.8%7.8%14.1%12.5%26.2%—
Current ratio4.89x4.51x4.24x3.94x3.70x3.23x—
Debt to equity0.00x0.00x0.00x0.00x0.00x0.01x—
Equity ratio80.3%79.5%78.6%77.4%76.3%74.4%—
Interest coverage—————23.32x10.42x
R&D as a share of sales24.0%25.2%26.6%24.1%20.6%20.1%—
Buybacks as a share of market value1.7%-1.8%-0.7%-0.9%0.5%-0.8%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue14.0%16.9%22.8%
Operating income25.9%19.4%27.8%
Net income23.1%19.1%32.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin75.1%73.5%73.3%72.6%
Operating margin27.1%23.9%24.5%24.4%
Net margin27.3%25.2%25.0%24.5%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings56.452.566.064.661.3109.6146.297.292.2109.9
Price to sales16.113.714.714.614.228.439.925.920.215.7

Market value over time

31 Oct 2016 to 21 Sept 2026, in USD

$5.73bn$43.13bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-2%21%10%-33%-7%91%66%50%33%50%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.